Mucus Relief Tablet
FDA Label NDC 57896-794

10 label sections · Submitted to the FDA by Geri-care Pharmaceuticals, Corp · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Geri-care Pharmaceuticals, Corp for the product Mucus Relief (NDC 57896-794). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, otc - keep out of reach of children, directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient (In Each Tablet)

Guaifenesin 400 mg

Purpose

Expectorant

Directions

  • take with full glass of water
  • do not exceed recommended dose
  • adults and children 12 years
    of age and over
    1 tablet, every 4 hours, while
    symptoms persist • do not
    exceed 6 doses in 24 hours
    children under 12 years of age
    do not use

* Please review the disclaimer below.